Intrexon reported $16.72M in Sales Revenues for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Sales Change
Agenus AGEN:US USD 22.77M 1.85M
Amgen AMGN:US USD 6.84B 187M
Anika Therapeutics ANIK:US USD 40.26M 607K
Arrowhead Research ARWR:US USD 31.58M 837K
AstraZeneca AZN:LN USD 10.98B 211M
Bluebird Bio BLUE:US USD 71K 1.45M
Bristol Myers Squibb BMY:US USD 11.41B 188M
Gilead Sciences GILD:US USD 7.39B 347M
GlaxoSmithKline GSK:LN GBP 7.38B 453M
Heron Therapeutics HRTX:US USD 26.56M 1.07M
Immunogen IMGN:US USD 15.38M 1.21M
Intrexon XON:US USD 16.72M 13.81M
Karyopharm Therapeutics KPTI:US USD 36.14M 3.53M
Ligand Pharmaceuticals LGND:US USD 62.51M 5.09M
Macrogenics MGNX:US USD 41.73M 15.73M
Mannkind MNKD:US USD 32.82M 13.93M
Merk MRK:US USD 13.83B 1.13B
Novartis NOVN:VX USD 12.84B 243M
Peregrine Pharmaceuticals PPHM:US USD 34.76M 1.93M
Rigel Pharmaceuticals RIGL:US USD 22.41M 7.41M
Roche Holding ROG:VX CHF 32.3B 207M
Sangamo Biosciences SGMO:US USD 26.46M 2.92M
Thermo Fisher Scientific TMO:US USD 11.45B 773M
Veracyte VCYT:US USD 75.59M 2.73M
Xencor XNCR:US USD 27.3M 2.88M
YTE INCY:US USD 823.3M 88.09M